2019 annual financial data

Sutro Biopharma, Inc. 2019 Net margin

Sutro Biopharma, Inc. 2019 net margin with verified reported values.

Direct answer

Net margin was -130.44%.

Operating income was -55,468,000 USD and net income was -55,744,000 USD.
Operating cash flow was -65,023,000 USD.

Get free Sutro Biopharma, Inc. email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
42,736,000 USD
Operating income
-55,468,000 USD
Net income
-55,744,000 USD
Operating cash flow
-65,023,000 USD